Observations of residual differentiation potential during lineage commitment.
We have recently described a subset of the multipotent progenitor pool that contains a common lymphoid progenitor. This subset of cells is lineage negative and expresses c-kit and Sca-1, but lacks expression of Thy 1.1 (Thyneg). Based on the observation that lethally irradiated mice transplanted with these cells die from anemia unless supported with competitor marrow, we hypothesized that these progenitors lacked erythroid potential. We analyzed the erythroid potential of these cells by transplanting them into mice allelic at the hemoglobin locus and compared their erythroid potential with the Thy-1.1low (Thylow) subset that contains hematopoietic stem cells. We also performed CFU-C assays in methylcellulose containing recombinant cytokines and determined erythroid contribution to colonies using in situ benzidine staining. Donor-derived hemoglobin was observed following transplant of Thyneg cells, even though 19 of 20 of these animals died from anemia. In contrast, recipients of Thylow cells showed complete donor-derived engraftment 30 days following transplant. While approximately 60% of day 4 colonies derived from Thyneg cells expressed hemoglobin, by day 11 less than 5% were hemoglobinized. In contrast, greater than 70% of the Thylow subset contained hemoglobinized cells at the end of the observation period. A similar transient appearance of myeloid progeny was also observed in colonies derived from c-kitlow Thyneg lymphoid progenitor cells. We conclude that these studies demonstrate commitment to the lymphoid lineage at the Thylow-to-Thyneg interface, and that the loss of erythroid and myeloid potential is gradual rather than abrupt. Hemoglobinized colonies may be undergoing apoptosis because of down-regulation of GATA-1 or because of a death signal from surrounding nonerythrocytic cells.
Slayton
W B
WB
Department of Pediatrics, University of Utah, Salt Lake City, Utah 84132, USA. bslayton@hci.utah.edu
Mojica
M P
MP
Pierce
L J
LJ
Spangrude
G J
GJ
D000740:Anemia / Q000209:etiology; D000818:Animals; D000943:Antigens, Differentiation / Q000032:analysis; D017209:Apoptosis; D015415:Biomarkers; D002454:Cell Differentiation; D019070:Cell Lineage; D003114:Colony-Forming Units Assay; D016207:Cytokines / Q000494:pharmacology; D004920:Erythropoiesis; D005434:Flow Cytometry; D006085:Graft Survival; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000187:drug effects; D006454:Hemoglobins / Q000032:analysis / Q000235:genetics; D008214:Lymphocytes / Q000166:cytology; D051379:Mice; D011828:Radiation Chimera; D011833:Radiation Injuries, Experimental / Q000209:etiology / Q000628:therapy; D011994:Recombinant Proteins / Q000494:pharmacology
D000943:Antigens, Differentiation; D015415:Biomarkers; D016207:Cytokines; D006454:Hemoglobins; D011994:Recombinant Proteins